Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Proteomics ; 144: 140-7, 2016 07 20.
Article in English | MEDLINE | ID: mdl-27216642

ABSTRACT

UNLABELLED: Mutations in the proto-oncogene c-KIT (KIT) are found in several cancers, and the site of these mutations differs markedly between cancer types. We used site directed mutagenesis to induce KIT(559), KIT(642) and KIT(816) mutations in primary human melanocytes (PHM) and we investigated the impact of each mutation on KIT function. We studied canonical KIT-signaling pathways by immunoblotting, and we used stable isotope labeling by amino acids in cell culture (SILAC) and kinase prediction models to identify kinases differently activated in respective mutants. We validated our results with the analysis of phosphorylation levels of selected substrates for each kinase. We concluded that CK1 ε and δ are more active in cell clones harboring KIT(559) and KIT(642) mutations, whereas PAK4 is more active in clones with KIT(816) mutation. Our findings might help to develop further therapeutic options for tumors with specific KIT mutations in different domains. BIOLOGICAL SIGNIFICANCE: Different types of cancers harbor mutations in the oncogene KIT. The use of small molecules inhibitors directly targeting KIT had a limited success in the treatment of patients with KIT mutant cancers. Our study describes specific phospho-proteome changes due to different KIT mutations, and provides targets of further therapeutic options.


Subject(s)
Melanocytes/chemistry , Mutation , Proteome/metabolism , Proto-Oncogene Proteins c-kit/genetics , Casein Kinases/metabolism , Cells, Cultured , Exons , Humans , Melanocytes/metabolism , Molecular Targeted Therapy , Neoplasms/genetics , Phosphoproteins/metabolism , Phosphorylation , Proto-Oncogene Mas , Signal Transduction , p21-Activated Kinases/metabolism
2.
Am J Physiol Lung Cell Mol Physiol ; 303(1): L12-9, 2012 Jul 01.
Article in English | MEDLINE | ID: mdl-22561460

ABSTRACT

We recently reported that integrin α(v)ß(3) is necessary for vascular barrier protection in mouse models of acute lung injury and peritonitis. Here, we used mass spectrometric sequencing of integrin complexes to isolate the novel ß(3)-integrin binding partner IQGAP1. Like integrin ß(3), IQGAP1 localized to the endothelial cell-cell junction after sphingosine-1-phosphate (S1P) treatment, and IQGAP1 knockdown prevented cortical actin formation and barrier enhancement in response to S1P. Furthermore, knockdown of IQGAP1 prevented localization of integrin α(v)ß(3) to the cell-cell junction. Similar to ß(3)-null animals, IQGAP1-null mice had increased pulmonary vascular leak compared with wild-type controls 3 days after intratracheal LPS. In an Escherichia coli pneumonia model, IQGAP1 knockout mice had increased lung weights, lung water, and lung extravascular plasma equivalents of (125)I-labeled albumin compared with wild-type controls. Taken together, these experiments indicate that IQGAP1 is necessary for S1P-mediated vascular barrier protection during acute lung injury and is required for junctional localization of the barrier-protective integrin α(v)ß(3).


Subject(s)
Acute Lung Injury/metabolism , Acute Lung Injury/pathology , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Pneumonia/metabolism , Pneumonia/pathology , ras GTPase-Activating Proteins/metabolism , Actins/metabolism , Acute Lung Injury/genetics , Animals , Cells, Cultured , Endothelial Cells/metabolism , Endothelial Cells/pathology , Integrin alphaVbeta3/metabolism , Lipopolysaccharides/pharmacology , Lung/metabolism , Lung/pathology , Lysophospholipids/metabolism , Mice , Mice, Knockout , Pneumonia/genetics , Protein Binding/physiology , Sphingosine/analogs & derivatives , Sphingosine/metabolism , ras GTPase-Activating Proteins/genetics
3.
Plant Biol (Stuttg) ; 14(3): 420-7, 2012 May.
Article in English | MEDLINE | ID: mdl-22117532

ABSTRACT

In axial organs of juvenile plants, the phytohormone auxin (indole-3-acetic acid, IAA) rapidly mediates cell wall loosening and hence promotes turgor-driven elongation. In this study, we used rye (Secale cereale) coleoptile sections to investigate possible effects of IAA on the proteome of the cells. In a first set of experiments, we document that IAA causes organ elongation via promotion of expansion of the rigid outer wall of the outer epidermis. A quantitative comparison of the proteome (membrane-associated proteins), using two-dimensional difference gel electrophoresis (2-D DIGE), revealed that, within 2 h of auxin treatment, at least 16 protein spots were up- or down-regulated by IAA. These proteins were identified using reverse-phase liquid chromatography electrospray tandem mass spectrometry. Four of these proteins were detected in the growth-controlling outer epidermis and were further analysed. One epidermal polypeptide, a small Ras-related GTP-binding protein, was rapidly down-regulated by IAA (after 0.5 h of incubation) by -35% compared to the control. Concomitantly, a subunit of the 26S proteasome was up-regulated by IAA (+30% within 1 h). In addition, this protein displayed IAA-mediated post-translational modification. The implications of these rapid auxin effects with respect to signal transduction and IAA-mediated secretion of glycoproteins (osmiophilic nano-particles) into the growth-controlling outer epidermal wall are discussed.


Subject(s)
Cotyledon/metabolism , Indoleacetic Acids/pharmacology , Plant Proteins/metabolism , Proteome/metabolism , Secale/metabolism , Cell Wall/drug effects , Cell Wall/metabolism , Cotyledon/drug effects , Cotyledon/genetics , Cotyledon/growth & development , Gene Expression Regulation, Plant/drug effects , Plant Epidermis/drug effects , Plant Epidermis/growth & development , Plant Growth Regulators/pharmacology , Proteome/drug effects , Secale/drug effects
4.
Plant Signal Behav ; 5(5): 509-17, 2010 May.
Article in English | MEDLINE | ID: mdl-20234181

ABSTRACT

The use of the grass coleoptile for the elucidation of the mechanism of cell elongation is a legacy of the classic experiments of Charles Darwin, who described this organ in 1880 as a "reddish sheath". In this study we quantified the growth of intact, etiolated rye (Secale cereale L.) seedlings and selected 3-day-old (growing) vs. 4-day-old (pierced) coleoptiles for a comparative analysis. Upon emergence of the reddish primary leaf on day 4 after sowing, growth slowed down by 70% and the sensitivity of the coleoptile to auxin (Indole-3-acetic acid) was lost, but turgor pressure was maintained. A quantitative comparison of the proteome (microsomal- and cytoplasmic protein fractions, respectively), using the two-dimensional difference gel electrophoresis (2-D DIGE)-technique, revealed that at least 28 proteins (spots) were differentially up- or down-regulated more than 1.5-fold. Eight of these proteins were identified by reverse-phase liquid chromatography-electrospray tandem mass spectrometry. Cessation of coleoptile growth was associated with the down-regulation (- 81 %) of subunit E of the vacuolar H(+)-ATPase (V-ATPase) and the up-regulation of enzymes involved in lignification (phenylalanine ammonia lyase) and wounding responses (xylanase inhibitor; two lipoxygenases). We conclude that the degradation of the V-ATPases, electrogenic proton pumps on the tonoplast and the membranes of the Golgi- dependent secretory pathway, may be the cause for the cessation of growth in turgid coleoptiles and the associated loss of auxin sensitivity. However, the intracellular signals that cause these proteomic changes have not yet been identified.


Subject(s)
Cotyledon/growth & development , Indoleacetic Acids/pharmacology , Proteomics/methods , Secale/growth & development , Secale/metabolism , Seedlings/growth & development , Seedlings/metabolism , Amino Acid Sequence , Chromatography, Liquid , Cotyledon/drug effects , Cotyledon/metabolism , Darkness , Electrophoresis, Gel, Two-Dimensional , Etiolation/drug effects , Microsomes/drug effects , Microsomes/metabolism , Molecular Sequence Data , Plant Proteins/chemistry , Plant Proteins/isolation & purification , Secale/drug effects , Seedlings/drug effects , Solubility , Tandem Mass Spectrometry
5.
Apoptosis ; 11(2): 209-19, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16502259

ABSTRACT

Synthetic peptides with sequences present in extracellular matrix protein fibronectin have been described to stimulate human monocytes. We describe now that one of these peptides, FN6, induces apoptotic effects on monocytes and we investigate the molecular mechanisms involved in the regulation of this response. Incubation of monocytes with FN6 induces the activation of the small GTPase Rac. In turn, Rac mediates the increase of both JNK and p38 activities in a sustained fashion, as well as the phosphorylation levels of their respective substrates c-Jun and ATF-2. FN6 also stimulates caspases -9 and -3 and the delayed proteolysis of its substrates PARP and D4-GDI. In addition, initiator caspases-1 and -5 were activated by FN6 treatment of monocytes but, in contrast to that observed for caspases-9 and -3, this effect was not dependent on JNK or p38 activities. These kinases also mediated the increase of Bax levels, but only in some conditions Bcl-2 depletion caused by the peptide. Moreover, whereas initially only caspase-1 is involved in caspase-3 activation, later on caspase-9 seems also to participate. Therefore, we demonstrate that FN6 stimulation allows multiple, JNK and p38-dependent and -independent interacting signals to regulate the apoptotic response in human monocytes.


Subject(s)
Apoptosis/drug effects , Fibronectins/chemistry , Monocytes/drug effects , Peptides/pharmacology , Apoptosis Regulatory Proteins/metabolism , Basic-Leucine Zipper Transcription Factors/metabolism , Cells, Cultured , DNA Fragmentation/drug effects , Enzyme Activation/drug effects , Guanine Nucleotide Dissociation Inhibitors/metabolism , Humans , Mitogen-Activated Protein Kinases/metabolism , Monocytes/cytology , Phosphorylation/drug effects , Poly(ADP-ribose) Polymerases/metabolism , Tumor Suppressor Proteins/metabolism , rac GTP-Binding Proteins/metabolism , rho Guanine Nucleotide Dissociation Inhibitor beta , rho-Specific Guanine Nucleotide Dissociation Inhibitors
6.
FEBS Lett ; 528(1-3): 133-8, 2002 Sep 25.
Article in English | MEDLINE | ID: mdl-12297293

ABSTRACT

The role of members of the mitogen-activated protein kinase (MAPK) family on tumor necrosis factor alpha (TNF-alpha)-mediated down-regulation of col1a1 gene was studied. TNF-alpha increased extracellular-regulated kinase and Jun-N-terminal kinase phosphorylation, but these effects were not related to its inhibitory effect on alpha1(I) procollagen (col1a1) mRNA levels. Phosphorylation of p38 MAPK was decreased in response to TNF-alpha, and the specific p38 MAPK inhibitor SB203580 mimicked the effect of TNF-alpha on col1a1 mRNA levels. Transforming growth factor beta (TGF-beta) increased p38 MAPK phosphorylation and SB203580 prevented the induction of col1a1 mRNA levels by TGF-beta. These results suggest that p38 MAPK plays an important role in regulating the expression of col1a1 in hepatic stellate cells in response to cytokines.


Subject(s)
Collagen Type I/genetics , Hepatocytes/drug effects , Hepatocytes/metabolism , Mitogen-Activated Protein Kinases/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transforming Growth Factor beta/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Animals , Apoptosis/drug effects , Base Sequence , Cell Line , Down-Regulation/drug effects , Enzyme Inhibitors/pharmacology , Hepatocytes/cytology , Imidazoles/pharmacology , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Phosphorylation , Pyridines/pharmacology , Rats , Sphingomyelin Phosphodiesterase/metabolism , Up-Regulation/drug effects , p38 Mitogen-Activated Protein Kinases
7.
Life Sci ; 68(1): 99-107, 2000 Nov 24.
Article in English | MEDLINE | ID: mdl-11132250

ABSTRACT

Neuropeptide Y (NPY) is a 36 amino acid peptide released in central and peripheral mammalian neurons, which appears to contribute to adiposity regulation by increasing food intake, thus promoting weight gain on animals. Nevertheless, little is known about NPY direct actions on white adipocytes. This trial, which was designed to test the possible effects of a new NPY antagonist, S.A.0204, on white adipose tissue, revealed that the administration of this novel molecule strongly ex vivo stimulates apoptosis and lipolysis in animals fed on a high-fat diet.


Subject(s)
Adipocytes/drug effects , Apoptosis/drug effects , Lipolysis/drug effects , Neuropeptide Y/antagonists & inhibitors , Obesity/metabolism , Adipocytes/cytology , Adipocytes/metabolism , Animals , Body Temperature , Disease Models, Animal , Feeding Behavior/drug effects , Female , Obesity/pathology , Rats , Rats, Wistar
8.
Arch Biochem Biophys ; 379(2): 353-62, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10898955

ABSTRACT

A short immunomodulating peptide (Pa) containing a defined structural motif present in a number of extracellular matrix proteins and autoantigens was found to stimulate human monocytes. Pa-induced apoptosis of isolated monocytes, as indicated by internucleosomal DNA cleavage, increased annexin V binding capacity and cleavage of caspase substrates, such as poly(ADP)ribosylpolymerase. In addition, Bcl-2 protein levels were downregulated during Pa-induced cell death. Nuclear extracts of monocytes incubated with Pa showed higher neutral, Ca(2+)-dependent DNase activity than those obtained from nontreated monocytes. Caspase inhibitors prevented Pa-induced apoptosis, Bcl-2 depletion, and DNase activation. Treatment of monocytes with Pa activated c-Jun N-terminal kinases and p38 kinase, in an acidic sphingomyelinase- and caspase-dependent fashion. Pa-induced apoptosis was blocked by selective inhibitors of p38 kinase (SB203580) and acidic sphingomyelinase (SR33557). These results indicate that JNK and p38 kinase stimulation as well as monocyte apoptosis induced by Pa could depend, at least in part, on early activation of acidic sphingomyelinase.


Subject(s)
Adjuvants, Immunologic/pharmacology , Apoptosis/drug effects , Monocytes/drug effects , Peptides/pharmacology , Adjuvants, Immunologic/antagonists & inhibitors , Adjuvants, Immunologic/chemistry , Amino Acid Motifs , Amino Acid Sequence , Annexin A5/metabolism , Autoantigens/chemistry , Autoantigens/immunology , Caspase Inhibitors , Caspases/metabolism , Cell Nucleus/drug effects , Cell Nucleus/enzymology , Cell Nucleus/metabolism , Cells, Cultured , DNA Fragmentation/drug effects , Deoxyribonucleases/metabolism , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Extracellular Matrix Proteins/chemistry , Extracellular Matrix Proteins/immunology , Guanine Nucleotide Dissociation Inhibitors/metabolism , Humans , MAP Kinase Signaling System/drug effects , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Molecular Sequence Data , Monocytes/cytology , Monocytes/enzymology , Monocytes/immunology , Peptides/antagonists & inhibitors , Peptides/chemistry , Peptides/immunology , Poly(ADP-ribose) Polymerases/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Sphingomyelin Phosphodiesterase/antagonists & inhibitors , Sphingomyelin Phosphodiesterase/metabolism , rho-Specific Guanine Nucleotide Dissociation Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...